- Home
- CRIS vs NTWK Comparison
CRIS vs NTWK Comparison
Compare CRIS & NTWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRIS
- NTWK
- Stock Information
- Founded
- CRIS 2000
- NTWK 1997
- Country
- CRIS United States
- NTWK United States
- Employees
- CRIS N/A
- NTWK N/A
- Industry
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- NTWK Computer Software: Prepackaged Software
- Sector
- CRIS Health Care
- NTWK Technology
- Exchange
- CRIS Nasdaq
- NTWK Nasdaq
- Market Cap
- CRIS 32.8M
- NTWK N/A
- IPO Year
- CRIS 2000
- NTWK 1998
- Fundamental
- Price
- CRIS $2.66
- NTWK $2.36
- Analyst Decision
- CRIS Strong Buy
- NTWK
- Analyst Count
- CRIS 3
- NTWK 0
- Target Price
- CRIS $23.00
- NTWK N/A
- AVG Volume (30 Days)
- CRIS 28.7K
- NTWK 32.3K
- Earning Date
- CRIS 05-06-2025
- NTWK 02-13-2025
- Dividend Yield
- CRIS N/A
- NTWK N/A
- EPS Growth
- CRIS N/A
- NTWK N/A
- EPS
- CRIS N/A
- NTWK N/A
- Revenue
- CRIS $10,259,000.00
- NTWK $62,048,128.00
- Revenue This Year
- CRIS N/A
- NTWK N/A
- Revenue Next Year
- CRIS N/A
- NTWK N/A
- P/E Ratio
- CRIS N/A
- NTWK N/A
- Revenue Growth
- CRIS 0.44
- NTWK 9.28
- 52 Week Low
- CRIS $2.60
- NTWK $2.28
- 52 Week High
- CRIS $17.49
- NTWK $3.34
- Technical
- Relative Strength Index (RSI)
- CRIS 30.08
- NTWK 34.69
- Support Level
- CRIS $2.83
- NTWK $2.42
- Resistance Level
- CRIS $3.15
- NTWK $2.53
- Average True Range (ATR)
- CRIS 0.17
- NTWK 0.11
- MACD
- CRIS -0.02
- NTWK -0.01
- Stochastic Oscillator
- CRIS 12.00
- NTWK 10.18
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.